Theraclion SA
PAR:ALTHE

Watchlist Manager
Theraclion SA Logo
Theraclion SA
PAR:ALTHE
Watchlist
Price: 0.63 EUR
Market Cap: 29.6m EUR
Section:
 

Relative Value

The Relative Value of one ALTHE stock under the Base Case scenario is hidden EUR. Compared to the current market price of 0.63 EUR, Theraclion SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALTHE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

15.2
P/S
P/S
Price to Sales
15.2
vs History
65
vs Industry
9
Median 3Y
14.5
Median 5Y
18.3
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.5
Industry
22.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-6.8
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-5
Median 5Y
-5
Industry
21.4
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
27
Median 3Y
3.2
Median 5Y
3.1
Industry
2.2
More Details
15.7
EV/S
EV/S
Enterprise Value to Sales
15.7
vs History
60
vs Industry
18
Median 3Y
13.2
Median 5Y
16.8
Industry
2.5
More Details
29.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
29.1
vs History
39
vs Industry
50
Median 3Y
19.3
Median 5Y
27
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-6.1
Industry
11.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-4.2
Industry
16.8
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-5.1
Industry
14.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-4.8
Industry
18.6
More Details
4
EV/IC
EV/IC
Enterprise Value to IC
4
vs History
23
vs Industry
74
Median 3Y
2
Median 5Y
2.6
Industry
1.9
More Details

Multiples Across Competitors

ALTHE Competitors Multiples
Theraclion SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Theraclion SA
PAR:ALTHE
29m EUR 15.2 -5.5 -5.2 -4.9
US
Abbott Laboratories
NYSE:ABT
222.2B USD 5.1 15.9 20.3 28.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
212.5B USD 22.1 77.4 59.4 72.5
US
Boston Scientific Corp
NYSE:BSX
145B USD 7.5 51.9 30.3 41.2
US
Stryker Corp
NYSE:SYK
140.1B USD 5.7 47.6 23.2 28.1
IE
Medtronic PLC
NYSE:MDT
128.6B USD 3.7 27 15.1 21.9
DE
Siemens Healthineers AG
XETRA:SHL
51.7B EUR 2.2 24.1 13.6 19.1
US
Becton Dickinson and Co
NYSE:BDX
58.6B USD 2.7 34.9 12.8 21.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.5B USD 13.6 55 39.5 43.8
US
Edwards Lifesciences Corp
NYSE:EW
49.9B USD 8.5 36.4 26.1 28.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.5B USD 2 17.8 13.2 16
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Theraclion SA
PAR:ALTHE
Average EV/EBITDA: 25.4
Negative Multiple: -5.2 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.3
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
59.4
26%
2.3
US
Boston Scientific Corp
NYSE:BSX
30.3
22%
1.4
US
Stryker Corp
NYSE:SYK
23.2
13%
1.8
IE
Medtronic PLC
NYSE:MDT
15.1
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.6
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.8
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.5
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
26.1
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
13.2
10%
1.3

See Also

Summary
ALTHE intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALTHE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALTHE stock valuation using valuation multiples.
Wall Street Estimates
ALTHE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALTHE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.